New Registry for Migraine Patients
The American Migraine Foundation (AMF) has developed a U.S. patient registry and biorepository for migraine. In collaboration with ZS, the AMF also has built a technology solution that sets out to collect a wide range of clinical and biological information from patients with migraine and other headache disorders, and to study that information over the course of an extended period of time.
AMF's American Registry for Migraine Research (ARMR) incorporates biological samples, leverages machine learning, and uses patient-reported outcomes, electronic health record and physician-captured data, and a mobile headache diary application to track the progress of patients over time.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Beyond the Prescription: The Role Pharma Plays in Digital Health Conversations
April 1st 2025As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.
